A Case of Vitiligo in a Hepatitis C Patient after Pegylated Interferon Treatment
C형 간염환자에서 Pegylated Interferon 치료 후 발생한 백반증 1예
인, 성일; 강, 희영
Korean journal of dermatology, 46(6):809-811, 2008
Korean journal of dermatology; 대한피부과학회지
The use of pegylated interferon (PEG-IFN) and ribavirin is considered standard therapy for patients with chronic hepatitis C. The treatment has been linked with a number of dermatologic manifestations such as alopecia, skin rash, pruritus, injection site inflammation and occasionally, with vitiligo. We report a case of vitiligo that occurred during treatment with PEG-IFN and ribavirin in a hepatitis C patient. The autoimmune adverse effects of IFN therapy should be considered in the treatment of vitiligo in such patients.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
Total Visit :5,293,875
Total Download :2,237,002
Today View :3,845
Ajou University Medical Information & Media Center 164 Worldcup-ro Yeongtong-gu Suwon 16499 Korea / TEL : 031-219-5312 / FAX : 031-219-5314 Copyright (c) Ajou University Medical Information & Media Center All Rights Reserved. AJOU Open Repository는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.